Larry J. Copeland

Larry J. Copeland's work focuses on clinical research in gynecologic cancers, particularly ovarian and endometrial cancer, with an emphasis on large multicenter clinical trials testing chemotherapy, targeted drugs, and immunotherapy combinations. Much of this research is conducted through cooperative clinical trial groups (such as GOG and NRG Oncology) that coordinate studies across many hospitals to test new cancer treatments and identify which patients benefit most from them. Prospective students would likely be exposed to large-scale clinical trial design, biomarker analysis, and treatment outcome research rather than laboratory-based work.

Publication output has grown over the past decade, dipping around 2018-2020 before rising substantially from 2021 onward, with recent years (2022-2025) showing the highest and most sustained activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026